Stay updated on Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T19:30:37.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a website transition and says the agency is adopting “Super Intelligence” terminology in place of “Artificial Intelligence.”
    Difference
    0.8%
    Check dated 2026-10-24T22:29:23.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record content appears unchanged.
    Difference
    0.1%
    Check dated 2026-10-17T22:36:39.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T22:26:06.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 is added to the record history and an older revision v3.6.6 is removed, updating the page to reflect the latest version history.
    Difference
    0.1%
    Check dated 2026-09-19T22:19:34.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry, v3.6.6, indicating a more recent update to the page. The previous revision, v3.6.5, has been removed from the current history.
    Difference
    0.1%
    Check dated 2026-08-29T20:03:55.000Z thumbnail image

Stay in the know with updates to Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ciforadenant with Daratumumab in Multiple Myeloma Clinical Trial page.